NEW YORK (GenomeWeb News) – Polyplus-transfection, a Strasbourg, France-based molecular and cell biology tools company, has inked a licensing deal covering zip nucleic acid (ZNA) oligonucleotides with German firm Metabion.
Under the terms of the agreement, Metabion has been granted a non-exclusive license to manufacture and commercialize Polyplus-transfection's ZNA oligonucleotides, a new technology that increases the affinity for nucleic acids without reducing specificity, the French firm said. Metabion, which is a custom nucleic acids supplier, has the right to sell the ZNA oligos for research and in vitro diagnostic applications, beginning March 22.
According to Polyplus-transfection, the ZNAs improve the performance of molecular hybridization techniques, such as PCR assays when used as primers or probes. The technology also increases the sensitivity of tests and the detection of mutations, the firm said.
Financial and other terms of the agreement were not disclosed.